Skip to Main Content

Paper Details

Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation.
J Allergy Clin Immunol
9
2023
Author NameAffiliation
Guohai ZhouBrigham and Women's Hospital and Harvard Medical School
George Caleb AlexanderJohns Hopkins Bloomberg School of Public Health, Johns Hopkins University School of Medicine, Md Center for Drug Safety and Effectiveness
  • 1 - 2

Datasets

Release 1.2